CNS Co.,Ltd. (4076) AI Stock Analysis

• Market Cap: ¥4.43B
• Dividend Yield: 4.91%
• Average Volume (3M): 12.68K
• Price to Earnings (P/E): 10.8
• Beta (1Y): 0.35
• Revenue Growth: 3.98%
• EPS Growth: -12.31%
• Country: JP
• Employees: 255
• Sector: Technology
• Sector Strength: 84
• Industry: Information Technology Services
• EPS (TTM): 141.22
• Shares Outstanding: 2,906,000
• 10 Day Avg. Volume: 26,590
• 30 Day Avg. Volume: 12,680
• PEG Ratio: 0.00
• Price to Book (P/B): 3.37
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 9.23
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 79 Outperform
• Price Target: ¥1,742.00 ▲(14.15%Upside)

CNS Co.,Ltd. is well-positioned in the Information Technology Services industry with strong financial performance as the most significant factor. The company's robust balance sheet, high profitability margins, and significant cash flow support its stability and growth potential. Valuation metrics suggest the stock may be undervalued, offering an attractive dividend yield. While technical analysis shows some mixed signals, the overall longer-term trend remains positive.

CNS Co.,Ltd. Business Overview & Revenue Model

Company Description

CNS Co., Ltd. (4076) is a company engaged in the technology and electronics sectors, focusing on developing and providing cutting-edge solutions and products. The company specializes in creating innovative systems and devices that cater to various industries, including telecommunications, consumer electronics, and industrial applications.

How the Company Makes Money

CNS Co., Ltd. generates revenue through the sale of its technology products and services. The company's primary revenue streams include the manufacturing and distribution of electronic components and systems for telecommunications and industrial applications, as well as consumer electronics. CNS Co., Ltd. may also engage in strategic partnerships and collaborations with other businesses to enhance its market reach and develop new technologies, contributing to its overall earnings.

CNS Co.,Ltd. Financial Statement Overview

Summary

CNS Co.,Ltd. showcases impressive financial health with consistent revenue growth, strong profitability margins, and robust balance sheet metrics. The company maintains low leverage, high returns on equity, and excellent cash flow ratios, positioning it well for future growth and stability.

Income Statement

CNS Co.,Ltd. exhibits strong income statement performance with consistent revenue growth, achieving a 11.15% increase in the latest year. Gross profit margin remains robust at 24.62%, indicating effective cost management. The net profit margin improved to 6.93%, reflecting efficiency in operations. EBIT and EBITDA margins are healthy, at 9.31% and 10.08% respectively, supporting profitability.

Balance Sheet

The company's balance sheet is solid with a low debt-to-equity ratio of 0.003, showcasing minimal leverage and financial risk. The return on equity is strong at 12.56%, indicating effective use of equity capital. The equity ratio stands at 74.42%, underscoring a strong equity base relative to total assets, enhancing financial stability.

Cash Flow

CNS Co.,Ltd. demonstrates positive cash flow dynamics with significant free cash flow growth of 88.45% year-on-year. The operating cash flow to net income ratio is healthy at 1.22, indicating strong cash generation relative to profitability. The free cash flow to net income ratio is excellent at 1.20, supporting liquidity and potential for reinvestment.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
6.72B	6.66B	5.99B	5.42B	4.84B	4.58B
	Gross Profit
1.62B	1.64B	1.51B	1.32B	1.15B	973.47M
	EBIT
523.49M	619.97M	559.10M	533.34M	458.24M	437.18M
	EBITDA
556.94M	671.18M	619.28M	620.28M	503.30M	498.12M
	Net Income Common Stockholders
403.98M	461.33M	433.10M	409.49M	336.71M	325.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.93B	3.57B	3.16B	3.01B	1.88B	1.56B
	Total Assets
4.18B	4.93B	4.55B	4.15B	3.14B	2.80B
	Total Debt
14.76M	10.65M	13.40M	5.65M	7.01M	8.33M
	Net Debt
-2.36B	-3.56B	-3.15B	-3.00B	-1.87B	-1.55B
	Total Liabilities
1.08B	1.26B	1.21B	1.11B	1.14B	1.08B
	Stockholders Equity
3.10B	3.67B	3.34B	3.04B	1.99B	1.72B
Cash Flow		Free Cash Flow
0.00	553.82M	293.94M	442.91M	125.44M	627.91M
	Operating Cash Flow
0.00	564.57M	352.80M	461.45M	183.12M	646.28M
	Investing Cash Flow
0.00	-80.65M	-125.97M	-23.01M	135.29M	11.54M
	Financing Cash Flow
0.00	-133.52M	-132.92M	633.75M	-64.02M	-151.45M

CNS Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1526.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4076, the sentiment is Positive. The current price of 1526 is below the 20-day moving average (MA) of 1569.09, above the 50-day MA of 1472.94, and above the 200-day MA of 1408.79, indicating a neutral trend. The MACD of 6.59 indicates Positive momentum. The RSI at 48.26 is Neutral, neither overbought nor oversold. The STOCH value of 9.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4076.

CNS Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3920	81 Outperform	¥5.28B	12.38		1.05%	13.25%	16826.25%
4076	79 Outperform	¥4.43B	10.81		4.91%	3.98%	-12.31%
3839	77 Outperform	¥4.71B	17.80		1.74%	10.32%	-2.06%
Sector *	62 Neutral	$11.80B	10.31	-7.45%	2.91%	7.43%	-7.78%
6942	59 Neutral	¥4.92B	46.36		―	-5.20%	133.74%
2375	48 Neutral	¥4.88B	―		0.42%	-5.06%	-52.77%
3997	48 Neutral	¥5.01B	―		1.56%	15.59%	32.56%